British Association for Psychopharmacology (BAP)

The BAP was founded in 1974, with the general intention of bringing together those from clinical and experimental disciplines as well as members of the pharmaceutical industry involved in the study of psychopharmacology. To this end the Association arranges scientific meetings, fosters research and teaching, encourages publication of results of research and provides guidance and information to the public on matters relevant to psychopharmacology, where appropriate.

Aims:
The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.

The BAP remit comprises two interlinked areas:
• The biological basis of brain and behaviour, and its alterations in psychiatric disorders.
• The study of treatments for disorders of brain and behaviour: the targets, mechanisms of action, effectiveness, and side-effects of current and novel treatments and drugs of abuse.